
Washington Racing to Overcome Alzheimer’s by 2025
VIDEO: Join “The Hill” in Washington, D.C. See health officials, policymakers, advocates, and medical experts offer a briefing on America’s Alzheimer’s goals and targets.

VIDEO: Join “The Hill” in Washington, D.C. See health officials, policymakers, advocates, and medical experts offer a briefing on America’s Alzheimer’s goals and targets.

Large, significant improvements in genetically-defined Alzheimer’s patients were seen in a clinical trial for tramiprosate. Learn about the important potential presented by these Phase-3 trial

Leading researchers from Johns Hopkins found that despite their very different causes and symptoms, stroke, Alzheimer’s, Parkinson’s, TBI and Huntington’s have a shared mechanism of

Years back, Accera completed clinical trials to show how diet can increase ketone levels to improve Alzheimer’s. Now, this subsidiary of Nestle Foods is creating

DRUG DEVELOPMENT: The breakthrough trial of aducanumab for Alzheimer’s recently made headline news. The FDA’s Fast Track program speeds up the development of new treatments

MAJOR ADVANCE – VIDEO & ARTICLE: A new experimental drug called “aducanumab” significantly slowed memory, thinking and cognitive decline in Alzheimer’s. It works by almost

MEMORY: In Alzheimer’s, it’s hard to find a way to boost memory. New research has uncovered a big reason why. It seems that over-boosting memory

DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look

VIDEO + ARTICLE: New 3D imaging technology is uncovering Alzheimer’s hard-to-solve secrets. See how sheets of light are shedding light on curing Alzheimer’s.

VIDEO – TODAY SHOW: The 3-year A4-Trial is using solanezumab to slow memory loss caused by Alzheimer’s. See how this government-sponsored nationwide trial is making

Kindness can become its own motive.We are made kind by being kind. (Eric Hoffer)

Exploring evidence on rosemary and lavender scents and cognitive performance.

If you couldn’t see your mashed potatoes, you probably wouldn’t eat them. That’s why what “The Red Plate Study” found was astonishing! Alzheimer’s patients eating from red plates consumed 25 percent more food than those eating from white plates. Find out why.

In a study on health & cynicism, people were asked how much they agree with statements such as, “I think most people would lie to get ahead,” and “It is safer to trust nobody”. The clear connection between their answers and their risk of dementia may startle you.

Lewis Hornby had a problem: his grandmother with dementia wasn’t drinking enough, causing her to get severely dehydrated.

Dr. Richard Taylor has Alzheimer’s and the right attitude!

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.
No spam, only news and updates.


